Transglutaminase-2 Cross-Linking Inhibition Strategy

The Transglutaminase-2 (TG2) Cross-Linking Inhibition Strategy targets the enzymatic mechanism responsible for creating covalent isopeptide bonds between aggregation-prone proteins in neurodegenerative diseases. TG2 catalyzes the formation of Nε-(γ-glutamyl)lysine cross-links between glutamine and lysine residues, creating irreversible protein-protein bonds that stabilize pathological aggregates of tau, α-synuclein, and huntingtin. By selectively inhibiting TG2's cross-linking activity at diseas...